New Delhi-based Varco Leg Care, a dedicated leg care brand, raised $0.5 million in seed funding while doubling its valuation within only 10 months. The recently concluded seed round was led by Sunicon Maiden Fund, an early-stage venture fund curated by Sunicon Ventures.
Varco Leg Care will be utilising the newly-acquired seed capital to strategically bolster capabilities across various fronts, which include enhancing offline touchpoints, advancing research and development (R&D) initiatives, and scaling and optimising marketing efforts. Additionally, the company would be allocating significant funds and resources in the near future towards enhancing its credibility, furthermore with the expansion of its existing IP portfolio (4 patents have been filed by Varco till date), as well as publishing its in-house-conducted clinical studies’ findings in various reputable medical journals.
Anondeep Ganguly, CEO, Varco Leg Care, said, “We are not only emphasizing and focusing on extensive clinical trials but also leveraging a pioneering low-friction technology to establish and validate that evidence. Going ahead, as we grow and scale exponentially and remain committed to delivering superlative leg health solutions, we shall continue placing the needs of our valued customers at the heart of our R&D initiatives."
As per a company statement, since its inception in 2022, Varco has served more than 5 lakh customers and expanded its presence to 3000+ medical stores across Mumbai, Bangalore, Delhi, and other Indian cities. Their products have also gained traction in Walmart USA and are available at pan-Indian organized retail outlets such as Guardian Pharmacy, Noble Plus, Wellness Forever, and others. Whereas on the online front, Varco Leg Care sells its products through its own website as well as via marketplaces like Amazon, Flipkart, 1MG, etc.
